title: IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.
abstract: Herpes simplex virus type 1 (HSV-1) is a leading cause of neurotrophic keratitis characterized by decreased corneal sensation because of damage to the corneal sensory fibers. We and others have reported regression of corneal nerves during acute HSV-1 infection. To determine whether denervation is caused directly by the virus or indirectly by the elicited immune response, mice were infected with HSV-1 and topically treated with dexamethasone (DEX) or control eye drops. Corneal sensitivity was measured using a Cochet-Bonnet esthesiometer and nerve network structure via immunohistochemistry. Corneas were assessed for viral content by plaque assay, leukocyte influx by flow cytometry, and content of chemokines and inflammatory cytokines by suspension array. DEX significantly preserved corneal nerve structure and sensitivity on infection. DEX reduced myeloid and T-cell populations in the cornea and did not affect viral contents at 4 and 8 days post infection. The elevated protein contents of chemokines and inflammatory cytokines on infection were greatly suppressed by DEX. Subconjunctival delivery of neutralizing antibody against IL-6 to infected mice resulted in partial preservation of corneal nerve structure and sensitivity. Our study supports a role for the immune response, but not local virus replication in the development of HSV-1-induced neurotrophic keratitis. IL-6 is one of the factors produced by the elicited inflammatory response to HSV-1 infection contributing to nerve regression.
authors: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: ana-chucair@ouhsc.edu.
authors: Ana J
authors: AJ
authors: Chucair-Elliott
authors: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors: Jeremy
authors: J
authors: Jinkins
authors: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors: Meghan M
authors: MM
authors: Carr
authors: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
authors: Daniel J J
authors: DJ
authors: Carr
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents; D057134:Antibodies, Neutralizing / Q000276:immunology; D018925:Chemokines / Q000276:immunology; D003315:Cornea / Q000473:pathology / Q000821:virology; D003316:Corneal Diseases / Q000150:complications / Q000276:immunology* / Q000473:pathology / Q000821:virology; D016207:Cytokines / Q000276:immunology; D003907:Dexamethasone / Q000627:therapeutic use; D018259:Herpesvirus 1, Human / Q000502:physiology*; D015850:Interleukin-6 / Q000276:immunology*; D016849:Keratitis, Herpetic / Q000150:complications / Q000276:immunology* / Q000473:pathology / Q000821:virology; D051379:Mice; D022423:Myeloid Cells / Q000187:drug effects; D009410:Nerve Degeneration / Q000150:complications / Q000209:etiology* / Q000473:pathology / Q000821:virology; D013601:T-Lymphocytes / Q000187:drug effects
chemical_list: D000893:Anti-Inflammatory Agents; D057134:Antibodies, Neutralizing; D018925:Chemokines; D016207:Cytokines; D015850:Interleukin-6; C577686:interleukin-6, mouse; D003907:Dexamethasone